查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1349406

尼古丁替代療法市場（產品類型：戒菸輔助設備和電子煙系統；分銷管道：零售藥房、醫院藥房和線上商店）- 全球行業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Nicotine Replacement Therapy Market (Product Type: Smoking Cessation Aids & Vaping System; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, & Online Stores) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

尼古丁替代療法市場 - 報告範圍

TMR 關於全球尼古丁替代療法市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球尼古丁替代療法的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。該報告也提供了2023年至2031年全球尼古丁替代療法市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解尼古丁替代療法市場。

市場概況
2023年市場價值 270 億美元
2031 年市場價值 521 億美元
年複合成長率 0.077%

該報告深入研究了全球尼古丁替代療法市場的競爭格局。全球尼古丁替代療法市場的主要參與者已經確定，並且每個參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球尼古丁替代療法市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 主要國家的監理格局分析
  • 供應/價值鏈分析
  • 最新動態/最新產品發布/關鍵策略
  • 主要地區吸菸成癮盛行率/發生率
  • 按地區分類接受 NRT 治療的個體的盛行率/發生率
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2017-2031
    • 戒菸輔助工具
      • 尼古丁吸入器
      • 尼古丁口香糖
      • 尼古丁含片
      • 尼古丁貼片
      • 其他
    • 電子煙系統
      • 電子煙
      • 加熱不燃燒煙草製品
  • 市場吸引力分析：按產品類型

第 7 章：全球市場分析與預測：按分銷管道

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：2017-2031年按通路
    • 零售藥局
    • 醫院藥房
    • 網路商店
  • 市場吸引力分析：按分銷管道

第 8 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 9 章：北美市場分析與預測

第 10 章：歐洲市場分析與預測

第 11 章：亞太市場分析與預測

第 12 章：拉丁美洲市場分析與預測

第 13 章：中東和非洲市場分析與預測

第 14 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類，2022 年
  • 公司簡介
    • Haleon Group of Companies
    • Pfizer, Inc.
    • McNeil AB (Johnson & Johnson)
    • SAABI NZ PTY Limited
    • PL Developments
    • Cipla Limited
    • BAT plc
    • JT International SA
    • Imperial Brands plc
    • Sparsha Pharma International Pvt. Ltd.
    • Pierre Fabre SA
    • Lucy Goods
    • Rubicon Research Pvt. Ltd.
    • JUUL Labs, Inc.
    • Fontem Holdings 4 BV
    • Philip Morris International, Inc.
    • Perrigo Company plc
Product Code: TMRGL54747

Nicotine Replacement Therapy Market - Scope of Report

TMR's report on the global nicotine replacement therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nicotine replacement therapy market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nicotine replacement therapy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nicotine replacement therapy market.

Market Snapshot
Market Value in 2023US$ 27 Bn
Market Value in 2031US$ 52.1 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nicotine replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nicotine replacement therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nicotine replacement therapy market.

The report delves into the competitive landscape of the global nicotine replacement therapy market. Key players operating in the global nicotine replacement therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nicotine replacement therapy market profiled in this report.

Key Questions Answered in Global Nicotine Replacement Therapy Market Report:

  • What is the sales/revenue generated by nicotine replacement therapy across all regions during the forecast period?
  • What are the opportunities in the global nicotine replacement therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nicotine Replacement Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global nicotine replacement therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nicotine replacement therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nicotine replacement therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nicotine Replacement Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nicotine Replacement Therapy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory landscape analysis by key countries
  • 5.2. Supply/Value chain analysis
  • 5.3. Recent Developments/Latest product launches/Key strategies
  • 5.4. Prevalence/Incidence of Smoking Addiction by key regions
  • 5.5. Prevalence/Incidence of Individuals Undergoing NRT Therapy by Region
  • 5.6. COVID-19 Pandemic Impact on Industry

6. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Smoking Cessation Aids
      • 6.3.1.1. Nicotine Inhalers
      • 6.3.1.2. Nicotine Gums
      • 6.3.1.3. Nicotine Lozenges
      • 6.3.1.4. Nicotine Patches
      • 6.3.1.5. Others
    • 6.3.2. Vaping System
      • 6.3.2.1. E-cigarettes
      • 6.3.2.2. Heat-not-burn Tobacco Products
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Retail Pharmacies
    • 7.3.2. Hospital Pharmacies
    • 7.3.3. Online Stores
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Nicotine Replacement Therapy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product Type, 2017-2031
    • 9.2.1. Smoking Cessation Aids
      • 9.2.1.1. Nicotine Inhalers
      • 9.2.1.2. Nicotine Gums
      • 9.2.1.3. Nicotine Lozenges
      • 9.2.1.4. Nicotine Patches
      • 9.2.1.5. Others
    • 9.2.2. Vaping System
      • 9.2.2.1. E-cigarettes
      • 9.2.2.2. Heat-not-burn Tobacco Products
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Retail Pharmacies
    • 9.3.2. Hospital Pharmacies
    • 9.3.3. Online Stores
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Nicotine Replacement Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Smoking Cessation Aids
      • 10.2.1.1. Nicotine Inhalers
      • 10.2.1.2. Nicotine Gums
      • 10.2.1.3. Nicotine Lozenges
      • 10.2.1.4. Nicotine Patches
      • 10.2.1.5. Others
    • 10.2.2. Vaping System
      • 10.2.2.1. E-cigarettes
      • 10.2.2.2. Heat-not-burn Tobacco Products
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Retail Pharmacies
    • 10.3.2. Hospital Pharmacies
    • 10.3.3. Online Stores
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Smoking Cessation Aids
      • 11.2.1.1. Nicotine Inhalers
      • 11.2.1.2. Nicotine Gums
      • 11.2.1.3. Nicotine Lozenges
      • 11.2.1.4. Nicotine Patches
      • 11.2.1.5. Others
    • 11.2.2. Vaping System
      • 11.2.2.1. E-cigarettes
      • 11.2.2.2. Heat-not-burn Tobacco Products
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Retail Pharmacies
    • 11.3.2. Hospital Pharmacies
    • 11.3.3. Online Stores
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Nicotine Replacement Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Smoking Cessation Aids
      • 12.2.1.1. Nicotine Inhalers
      • 12.2.1.2. Nicotine Gums
      • 12.2.1.3. Nicotine Lozenges
      • 12.2.1.4. Nicotine Patches
      • 12.2.1.5. Others
    • 12.2.2. Vaping System
      • 12.2.2.1. E-cigarettes
      • 12.2.2.2. Heat-not-burn Tobacco Products
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Retail Pharmacies
    • 12.3.2. Hospital Pharmacies
    • 12.3.3. Online Stores
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Nicotine Replacement Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Smoking Cessation Aids
      • 13.2.1.1. Nicotine Inhalers
      • 13.2.1.2. Nicotine Gums
      • 13.2.1.3. Nicotine Lozenges
      • 13.2.1.4. Nicotine Patches
      • 13.2.1.5. Others
    • 13.2.2. Vaping System
      • 13.2.2.1. E-cigarettes
      • 13.2.2.2. Heat-not-burn Tobacco Products
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Retail Pharmacies
    • 13.3.2. Hospital Pharmacies
    • 13.3.3. Online Stores
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2022
  • 14.3. Company Profiles
    • 14.3.1. Haleon Group of Companies
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Pfizer, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. McNeil AB (Johnson & Johnson)
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. SAABI NZ PTY Limited
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. PL Developments
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Cipla Limited
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. BAT plc
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. JT International SA
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Imperial Brands plc
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Sparsha Pharma International Pvt. Ltd.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Pierre Fabre S.A.
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. Financial Overview
      • 14.3.11.4. SWOT Analysis
      • 14.3.11.5. Strategic Overview
    • 14.3.12. Lucy Goods
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Product Portfolio
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. SWOT Analysis
      • 14.3.12.4. Strategic Overview
    • 14.3.13. Rubicon Research Pvt. Ltd.
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. Financial Overview
      • 14.3.13.4. SWOT Analysis
      • 14.3.13.5. Strategic Overview
    • 14.3.14. JUUL Labs, Inc.
      • 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.14.2. Product Portfolio
      • 14.3.14.3. Financial Overview
      • 14.3.14.4. SWOT Analysis
      • 14.3.14.5. Strategic Overview
    • 14.3.15. Fontem Holdings 4 B.V.
      • 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.15.2. Product Portfolio
      • 14.3.15.3. Financial Overview
      • 14.3.15.4. SWOT Analysis
      • 14.3.15.5. Strategic Overview
    • 14.3.16. Philip Morris International, Inc.
      • 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.16.2. Product Portfolio
      • 14.3.16.3. Financial Overview
      • 14.3.16.4. SWOT Analysis
      • 14.3.16.5. Strategic Overview
    • 14.3.17. Perrigo Company plc
      • 14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.17.2. Product Portfolio
      • 14.3.17.3. Financial Overview
      • 14.3.17.4. SWOT Analysis
      • 14.3.17.5. Strategic Overview

List of Tables

  • Table 01: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2032
  • Table 03: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System, 2017-2033
  • Table 04: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 08: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System, 2017-2032
  • Table 09: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 10: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 11: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 13: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 14: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 15: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 17: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 18: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 19: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 22: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 23: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 24: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 25: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 28: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 29: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 30: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Nicotine Replacement Therapy Market Value Share, by Product Type, 2022
  • Figure 03: Global Nicotine Replacement Therapy Market Value Share, by Distribution Channel, 2022
  • Figure 04: Global Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 05: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Smoking Cessation Aids, 2017-2031
  • Figure 06: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Vaping System, 2017-2031
  • Figure 07: Global Nicotine Replacement Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 08: Global Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 09: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 10: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 11: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Online Stores, 2017-2031
  • Figure 12: Global Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 13: Global Nicotine Replacement Therapy Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 14: Global Nicotine Replacement Therapy Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 15: North America Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: North America Nicotine Replacement Therapy Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 17: North America Nicotine Replacement Therapy Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 18: North America Nicotine Replacement Therapy Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 19: North America Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type 2023-2031
  • Figure 20: North America Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 21: North America Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 22: Europe Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Europe Nicotine Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 26: Europe Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 27: Europe Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 28: Europe Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 29: Asia Pacific Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Asia Pacific Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 31: Asia Pacific Nicotine Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 32: Asia Pacific Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 33: Asia Pacific Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 34: Asia Pacific Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 35: Asia Pacific Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 36: Latin America Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Latin America Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 38: Latin America Nicotine Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 39: Latin America Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 40: Latin America Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 41: Latin America Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 42: Latin America Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 43: Middle East and Africa Nicotine Replacement Therapy Market Value (US$ Mn), 2017-2031
  • Figure 44: Middle East and Africa Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Middle East and Africa Nicotine Replacement Therapy Market Attractiveness, by Country/Sub-region, 2023-2031
  • Figure 46: Middle East and Africa Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 47: Middle East and Africa Nicotine Replacement Therapy Market Attractiveness by Product Type, 2023-2031
  • Figure 48: Middle East and Africa Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 49: Middle East and Africa Nicotine Replacement Therapy Market Attractiveness, by Distribution Channel, 2023-2031
  • Figure 50: Company Share Analysis Nicotine Replacement Therapy, 2022